TANVEX BIOPHARMA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.65 TWD | +2.47% |
|
+11.89% | -29.88% |
| 06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
| 06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
Quotes 5-day view
End-of-day quote Taiwan S.E.| 24/06/2024 | 25/06/2024 | 26/06/2024 | 27/06/2024 | 28/06/2024 | |
|---|---|---|---|---|---|
| Last | 43.85 NT$ | 42.1 NT$ | 44 NT$ | 44.55 NT$ | 45.65 NT$ |
| Volume | 565 720 | 119 066 | 244 001 | 220 160 | 239 469 |
| Change | +7.48% | -3.99% | +4.51% | +1.25% | +2.47% |
| Opening | 41.60 | 43.00 | 42.40 | 44.95 | 45.05 |
| High | 44.85 | 43.20 | 44.30 | 45.90 | 46.00 |
| Low | 41.30 | 41.60 | 42.35 | 44.40 | 45.05 |
Performance
| 1 day | +2.47% | ||
| 1 week | +11.89% | ||
| 1 month | +16.45% | ||
| 3 months | -6.26% | ||
| 6 months | -29.88% | ||
| Current year | -29.88% | ||
| 1 year | -39.21% | ||
| 3 years | -73.70% | ||
| 5 years | -79.20% |
Volumes
marketsDaily volume
239 469
Avg. Volume 20 sessions
160 989
Avg. Volume 20 sessions TWD
7 349 147.85
Avg. Volume 20 sessions USD
226 368.45
Record volume 1
3 787 967
Record volume 2
3 152 645
Record volume 3
3 130 498
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (TWD)
230 493 951
Capitalization (USD)
230 493 951
Net sales ()
61
Number of employees
167
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
59.81 %
Free-Float capitalization (TWD)
137 867 422
Free-Float capitalization (USD)
137 867 422
Average Daily Capital Traded
3.19%
Highs and lows
1 week
41.60
46.00
1 month
39.0046.00
Current year
35.0566.50
1 year
35.0578.00
3 years
35.05245.22
5 years
35.05299.78
10 years
35.051 034.21
Indicators
Moving average 5 days
44.03
Moving average 20 days
41.52
Moving average 50 days
42.37
Moving average 100 days
49.27
Price spread / (MMA5)
-3.55%
Price spread / (MMA20)
-9.05%
Price spread / (MMA50)
-7.19%
Price spread / (MMA100)
+7.93%
STIM
RSI 9 days
70.46
RSI 14 days
64.10
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.47% | +11.89% | -29.88% | -39.21% | 230M | ||
| -0.80% | +0.00% | +15.20% | +33.19% | 121B | ||
| +0.02% | -0.20% | +19.67% | +46.27% | 113B | ||
| -1.87% | +9.90% | +18.95% | +14.97% | 26.02B | ||
| -0.02% | -5.06% | -23.86% | -25.54% | 19.39B | ||
| -1.88% | -3.38% | -19.03% | -32.36% | 15.91B | ||
| -2.00% | -8.61% | -20.90% | -19.98% | 15.09B | ||
| -0.36% | -3.21% | -46.14% | -37.10% | 15.06B | ||
| +0.03% | -1.69% | +63.85% | +37.97% | 14.93B | ||
| +2.50% | +2.30% | +4.49% | +45.99% | 13.85B | ||
| +0.07% | -1.46% | +116.20% | +217.54% | 10.8B | ||
| +2.65% | +16.29% | +139.15% | +264.88% | 9.06B | ||
| -4.14% | +0.76% | +20.24% | +51.20% | 8.22B | ||
| -0.83% | +3.94% | -26.39% | -35.84% | 8.07B | ||
| +0.72% | +6.67% | +8.28% | +52.81% | 7.82B | ||
| +0.96% | -1.82% | -3.56% | +28.63% | 7.45B | ||
| Average | -0.16% | +1.17% | +14.77% | +37.71% | ||
| Weighted average by Cap. | -0.43% | +0.30% | +15.51% | +35.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -29.88% | ||
| 2023 | -38.13% | ||
| 2022 | -39.59% | ||
| 2021 | +55.35% | ||
| 2020 | -16.42% | ||
| 2019 | -28.40% | ||
| 2018 | -35.50% | ||
| 2017 | -37.44% | ||
| 2016 | -35.73% | ||
| 2015 | +86.82% |
- Stock Market
- Equities
- 6541 Stock
- Quotes Tanvex BioPharma, Inc.
